title: LPHN3, a presynaptic adhesion-GPCR implicated in ADHD, regulates the strength of neocortical layer 2/3 synaptic input to layer 5.
abstract: BACKGROUND
  Latrophilins (LPHNs) are a small family of neuronal adhesion-GPCRs originally discovered as receptors for the black widow spider toxin α-latrotoxin. Mutations in LPHN3 have recently been identified as risk factors for attention deficit hyperactivity disorder (ADHD) in humans, but their physiological function has remained elusive. In this study, we tested two hypotheses regarding LPHN3 function: (1) LPHN3 regulates synaptic transmission by modulating probability of release; and (2) LPHN3 controls synapse development and the abundance of synapses.
  
  
  RESULTS
  We manipulated LPHN3 expression in mouse layer 2/3 (L2/3) pyramidal neurons and examined the consequences on the L2/3 to L5 cortical microcircuit. Employing an optogenetic strategy combined with shRNA knockdown of LPHN3, we found that LPHN3 did not influence probability of release at synapses formed by L2/3 neurons onto L5 pyramidal cells. The strength of L2/3 afferent input to L5, however, was weakened by loss of LPHN3. Using Synaptophysin-GFP as an anatomical marker of presynaptic terminals, we found that the density of synapses formed by L2/3 axons in L5 was reduced when LPHN3 was lost. Finally, we investigated the structural organization of the extracellular domain of LPHN3. We used single particle negative stain electron microscopy to image the extracellular domain of LPHN3 and showed that the Olfactomedin and Lectin domains form a globular domain on an elongated stalk. Cell-based binding experiments with mutant proteins revealed that the Olfactomedin domain was required for binding to FLRT3, whereas both the Olfactomedin and Lectin domains were involved in binding to Teneurin 1. Mutant LPHN3 lacking the Olfactomedin domain was not capable of rescuing the deficit in presynaptic density following knockdown of endogenous LPHN3.
  
  
  CONCLUSIONS
  We find that LPHN3 regulates the number of synapses formed by L2/3 neurons in L5 and the strength of synaptic drive from the L2/3-L5 pathway. The Olfactomedin domain of LPHN3 is required for this effect on synapse number and binding to its postsynaptic ligand FLRT3. We propose that LPHN3 functions in synaptic development and is important in determining the connectivity rates between principal neurons in the cortex.
authors.forename: Matthew L
authors.initials: ML
authors.lastname: O'Sullivan
authors.forename: Francesca
authors.initials: F
authors.lastname: Martini
authors.forename: Sventja
authors.initials: S
authors.lastname: von Daake
authors.forename: Davide
authors.initials: D
authors.lastname: Comoletti
authors.affiliation: Neurobiology Section, Division of Biology, University of California San Diego, La Jolla, CA 92093, USA. anirvan.ghosh@roche.com.
authors.forename: Anirvan
authors.initials: A
authors.lastname: Ghosh
mesh_terms: D000818:Animals; D002540:Cerebral Cortex / Q000166:cytology / Q000502:physiology*; D019706:Excitatory Postsynaptic Potentials; D051379:Mice; D043562:Receptors, G-Protein-Coupled / Q000737:chemistry / Q000502:physiology*; D018000:Receptors, Peptide / Q000737:chemistry / Q000502:physiology*; D013569:Synapses / Q000502:physiology*
chemical_list: D043562:Receptors, G-Protein-Coupled; D018000:Receptors, Peptide; C000592543:Adgrl3 protein, mouse
references.citation: Nature. 2012 Mar 18;484(7393):237-41
references.pmid: 22426000
references.citation: Pediatr Res. 2011 May;69(5 Pt 2):69R-76R
references.pmid: 21289544
references.citation: J Biol Chem. 2012 Mar 16;287(12):9399-413
references.pmid: 22262843
references.citation: EMBO J. 2012 Mar 21;31(6):1364-78
references.pmid: 22333914
references.citation: Nat Rev Neurosci. 2008 Jun;9(6):423-36
references.pmid: 18464791
references.citation: Nature. 2012 Mar 18;484(7393):201-7
references.pmid: 22425994
references.citation: Mol Cell Neurosci. 2006 Oct;33(2):136-49
references.pmid: 16919471
references.citation: Science. 2012 Oct 26;338(6106):536-40
references.pmid: 23042292
references.citation: Eur Neuropsychopharmacol. 2013 Jun;23(6):458-68
references.pmid: 23245769
references.citation: Curr Opin Neurobiol. 2011 Feb;21(1):132-43
references.pmid: 20832286
references.citation: Mol Psychiatry. 2010 Nov;15(11):1053-66
references.pmid: 20157310
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2011 Jan;156B(1):11-8
references.pmid: 21184580
references.citation: Nature. 2007 Jan 11;445(7124):168-76
references.pmid: 17151600
references.citation: Neuron. 2012 Mar 22;73(6):1116-26
references.pmid: 22445340
references.citation: Neuron. 2012 Mar 8;73(5):903-10
references.pmid: 22405201
references.citation: Int J Biochem Cell Biol. 2009 May;41(5):990-3
references.pmid: 18723111
references.citation: Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12113-8
references.pmid: 21724987
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2012 Oct;159B(7):776-85
references.pmid: 22851411
references.citation: Annu Rev Neurosci. 2001;24:933-62
references.pmid: 11520923
references.citation: Biol Proced Online. 2004;6:23-34
references.pmid: 15103397
references.citation: Gene Expr Patterns. 2003 Aug;3(4):397-405
references.pmid: 12915301
references.citation: Bioinformatics. 2011 Sep 1;27(17):2453-4
references.pmid: 21727141
references.citation: Neuron. 2011 Oct 6;72(1):111-23
references.pmid: 21982373
references.citation: Science. 1993 Oct 29;262(5134):754-7
references.pmid: 7901909
references.citation: J Struct Biol. 1996 Jan-Feb;116(1):190-9
references.pmid: 8742743
references.citation: Structure. 2007 Jun;15(6):693-705
references.pmid: 17562316
references.citation: Nature. 1993 Dec 9;366(6455):569-72
references.pmid: 7902955
references.citation: J Biol Chem. 2014 Jan 3;289(1):387-402
references.pmid: 24273166